Ascendis Pharma to list ordinary shares directly on Nasdaq, replacing ADSs on April 20, 2026

Ascendis Pharma announced it will list its ordinary shares directly on Nasdaq starting April 20, 2026, exchanging all American Depositary Shares (ADSs) for ordinary shares at a 1:1 ratio. This move aims to simplify its listing structure, broaden global investor access, and potentially increase institutional ownership and trading liquidity. The ordinary shares will trade under the existing ticker symbol ASND but with new identification numbers. Investors can find more details on the company's website ahead of the transition.